Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 112Breast Neoplasms 87Carcinoma, Non-Small-Cell Lung 85Glioblastoma 72Ovarian Neoplasms 61Brain Neoplasms 45Lung Neoplasms 41Glioma 41Fallopian Tube Neoplasms 41Neoplasms 38Colonic Neoplasms 34Gliosarcoma 33Carcinoma, Renal Cell 32Rectal Neoplasms 31Neoplasm Metastasis 29Pancreatic Neoplasms 19Carcinoma, Hepatocellular 19Melanoma 18Adenocarcinoma of Lung 18Astrocytoma 15Kidney Neoplasms 13Stomach Neoplasms 12Prostatic Neoplasms 12Uterine Cervical Neoplasms 11Oligodendroglioma 11Liver Neoplasms 11Esophageal Neoplasms 11Sarcoma 10Adenocarcinoma, Bronchiolo-Alveolar 10Central Nervous System Neoplasms 9

Interventions

Radiotherapy, Intensity-Modulated 1Radiotherapy 1Oxaliplatin 1Mammaplasty 1Intermittent Pneumatic Compression Devices 1Fondaparinux 1Fibrin Tissue Adhesive 1Educational Status 1Dexamethasone 1Counseling 1Cathartics 1Carbohydrates 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Postoperative Complications × Bevacizumab × Clear all
NCT00828672 2019-07-10

AXEBEAM

Universitaire Ziekenhuizen KU Leuven

Phase 2 Completed
84 enrolled 19 charts
Gastrointestinal

Postoperative Complications, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡